Transcriptomic signatures in sepsis and a differential response to steroids: from the VANISH randomized trial
<strong>Rationale:</strong> There remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration but conflicting survival effects. Two transcriptomic sepsis response signatures (SRS) have been identified. SRS1 is relatively immunosuppresse...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Thoracic Society
2018
|